{"text": ["Lilly's", "REYVOW\u2122", "(lasmiditan),", "The", "First", "and", "Only", "Medicine", "in", "a", "New", "Class", "of", "Acute", "Treatment", "for", "Migraine,", "Receives", "FDA", "Approval"], "created_at": "2019-10-11 19:48:00"}
{"text": ["UPDATE", "1-Eli", "Lilly's", "migraine", "treatment", "wins", "U.S.", "FDA", "approval"], "created_at": "2019-10-11 19:38:01"}
{"text": ["Eli", "Lilly's", "migraine", "treatment", "wins", "U.S.", "FDA", "approval"], "created_at": "2019-10-11 18:39:56"}
{"text": ["Pharma", "Stock", "Roundup:", "NVS'", "New", "Eye", "Drug", "Gets", "FDA", "Nod,", "NVO,", "GSK,", "PFE", "Sign", "Deals"], "created_at": "2019-10-11 15:03:03"}
{"text": ["Gilead-Galapagos", "Report", "Efficacy", "&", "Safety", "Results", "on", "RA", "Drug"], "created_at": "2019-10-11 13:19:01"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Therapix", "Extends", "Merger", "Deadline,", "Five", "Prime", "Restructures,", "Gilead-Galapagos", "Rheumatism", "Drug", "Readout"], "created_at": "2019-10-11 12:14:27"}
